Age Related Macular Degeneration Market 2023 Vision | Recording USD 2,200 Mn Along With F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals
As per the study offered by Market Research Future (MRFR), the global age related macular degeneration market is set to expand at a CAGR of 8.3% during the forecast period 2018 to 2023. The valuation of the market is predicted to grow from USD 1.37 Bn at the end of 2017 to 2.21 Bn by 2023-end. The growing patient pool of a geriatric population is leading the expansion of the market. It is estimated that AMD contributes significantly towards visual loss among the elderly population. In addition, the global aging population is expected to get doubled by the end of 2020. It is presumed to aid the proliferation of the age related macular degeneration market over the assessment period.
The expiry of drug patents for widely accepted branded drugs have opened new avenues of growth opportunities for the market participants. Investments are prognosticated to flow towards the development in the formulas of existing drugs for enhanced efficiency. In addition, expired drug patents have paved the way for a reduction in price points, thus, augmenting the global age related macular degeneration market.
Free Sample Copy of Report available @ https://www.marketresearchfuture.com/sample_request/5736
The market is lucrative at present, and the rising awareness about the diseases is further expected to boost the growth trajectory of the age related macular degeneration market in the foreseeable future. On the flip side, unfavorable reimbursement policies and the high cost of drugs remain impediments to the market growth.
By type, the global age related macular degeneration market has been segmented into wet AMD and dry AMD.
By stages, the age related macular degeneration market has been segmented into intermediate AMD, early AMD, and late AMD.
By age group, the global age related macular degeneration market has been segmented into above 75, above 60, and above 40.
By diagnosis & treatment, the age related macular degeneration market has been segmented into treatment and diagnosis.
By route of administration, the global age related macular degeneration market is segmented into intravitreal, intravenous, and others.
By end-user, the age related macular degeneration market has been segmented into hospitals & clinics, diagnostic centers, academic research institutes, and others.
The age related macular degeneration market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is projected to hold a dominant share of the global market through the forecast period. The rising burden of the disease in the region is expected to drive the proliferation of the regional market. According to the Centers for Disease Control and Prevention (CDC), 1.8 million people were suffering from the disease in 2015 in the U.S.
Europe is an important growth pocket placed at the second position in the marketplace. It is predicted to benefit from rising geriatric population and increasing healthcare expenditure. Meanwhile, Asia Pacific is likely to emerge as the fastest growing regional market for AMD over the assessment period. The factors that are responsible for favoring the expansion of the age-related macular degeneration market in the region are rising healthcare expenditure, increasing prevalence of eye-disorders, growing geriatric population, etc.
MRFR in their report on the age-related macular degeneration market included Regeneron Pharmaceutical Inc., F. Hoffmann-La Roche AG, Santen Pharmaceuticals, Novartis AG, Bayer AG, and others as possible market influencers.
In January 2019, researchers from the University of Liverpool discovered new genes that can be linked with age-related macular degeneration. This could lead to proper treatment for the disease as the root cause for the disease is still unclear.
In November 2018, the European Court of Justice has determined that Avastin by Roche can be reimbursed for the treatment of age-related macular degeneration despite the challenge imposed by Bayer and Novartis.
In December 2018, the U.S. based Ophthotech Corp. has scrapped the clinical trials of C5 inhibitor for the treatment of wet age-related macular degeneration in spite of successful phase 2a results exhibiting tolerance for imura (avacincaptad pegol) in combination with ranibizumab (Lucentis).
In December 2018, a team of British scientists has announced that they are piloting an eye drop aimed at treating age-related macular degeneration (AMD). The researchers have concluded successful trials on rabbits and pigs and will be tried on human eyes in 2019.
Browse Premium Report Details @ https://www.marketresearchfuture.com/reports/age-related-macular-degeneration-market-5736
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Age Related Macular Degeneration Market 2023 Vision | Recording USD 2,200 Mn Along With F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals here
News-ID: 1814720 • Views: 484
More Releases from Market Research Future
Medical Aesthetics Industry Size, Market Growth, Key Company Profile, Comprehens …
The “Global Medical Aesthetics Market Is Showing High Probabilities Of Achieving A CAGR Of 11% Between 2018 And 2023”. Medical aesthetics Industry covers the aesthetical aspect of the healthcare sector and includes well-being, noticeable skin changes, peripheral appearance, and image of the patient. Medical aesthetics include fuses beauty and healthcare services and are getting substantial traction not just from demand for upliftment of the looks but anti-aging as well. There are several
Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
More Releases for AMD
CPU Market Forecast by 2025: Sun, Intel, AMD, NVIDIA, Qualcomm
Learn how to build the strategy and business case to implement. The CPU Market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The Top key vendors in CPU Market include are
Graphics Card Market Overview: Intelligence Players (AMD, ASUS, MSI, Gigabyte)
HTF MI recently launched the Graphics Card study with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Graphics Card Forecast
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
Global Deep Learning Chipset Market 2018 - Xilinx, AMD, NVIDIA, ARM
Apex Market Reports, recently published a detailed market research study focused on the “Deep Learning Chipset Market” across the global, regional and country level. The report provides 360° analysis of “Deep Learning Chipset Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deep
congatec partners with AMD for long-time support of AMD Geode™ processors
Deggendorf, Germany, 16 January 2018 * * * congatec – a leading technology company for embedded computer modules, single board computers and embedded design and manufacturing services – and AMD have teamed together to provide extended life cycle support for one of the world's longest-serving x86 processors. The result is that AMD Geode™ processor boards from congatec will have planned availability until the end of 2021. “With the
Professional SMS Market 2017-22: 3Cinteractive, Accrete, AMD Telecom S.A
HTF MI published a new industry research that focuses on Professional SMS market and delivers in-depth market analysis and future prospects of Global Professional SMS market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is